Latest News

Xylazine – often called “tranq” – is a drug adulterant that DEA has detected in a growing number of overdose deaths, despite the FDA authorizing it only for veterinary use.

December is National Impaired Driving Prevention Month. Check out these resources from DEA and the Substance Abuse and Mental Health Services Administration (SAMHSA) to learn how best to protect your kids.

The National Family Partnership and the DEA have announced the winners of the 2022 Red Ribbon Week Photo Contest!

Today’s youth have become Generation Wrecked.

The Drug Enforcement Administration is alerting the public of a sharp nationwide increase in the lethality of fentanyl-laced fake prescription pills.

One in five young adults and one in ten teens reported using prescription drugs off-script, according to a study commissioned by nonprofit charity Song for Charlie.

Biking while stoned leads to thousands of serious crashes each year, a new study suggests.

The U.S. Drug Enforcement Administration today announced the results of an enforcement operation that spanned from May to September and resulted in significant fentanyl seizures across the United States.

The Drug Enforcement Administration is advising the public of an alarming emerging trend of colorful fentanyl available across the United States.  In August 2022, DEA and our law enforcement partners seized brightly-colored fentanyl and fentanyl pills in 18 states.  Dubbed “rainbow fentanyl” in the media, this trend appears to be a new method used by drug cartels to sell highly addictive and potentially deadly fentanyl made to look like candy to children and young people.

The National Suicide Prevention Lifeline is transitioning its number to 988.